UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice

British journal of haematology, 2018-03, Vol.180 (5), p.666-679

2018

Volltextzugriff (PDF)

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

The lancet oncology, 2019-01, Vol.20 (1), p.43-56

2019

Volltextzugriff (PDF)

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

Blood, 2013-10, Vol.122 (16), p.2856-2863

2013

Volltextzugriff (PDF)

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4111-4116

2012

Volltextzugriff (PDF)

Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1349-1355

2011

Volltextzugriff (PDF)

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Journal of clinical oncology, 2014-04, Vol.32 (12), p.1236-1241

2014

Volltextzugriff (PDF)

Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma at the Time of Second or Subsequent Remission: Long-Term Follow-Up

Journal of clinical oncology, 2007-06, Vol.25 (18), p.2554-2559

2007

Volltextzugriff (PDF)

Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study

Haematologica (Roma), 2023-03, Vol.108 (3), p.822-832

2023

Volltextzugriff (PDF)

Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice

Cellular and molecular gastroenterology and hepatology, 2021-01, Vol.12 (5), p.1543-1565

2021

Volltextzugriff (PDF)

Fertility and sexual function in long‐term survivors of haematological malignancy: using patient‐reported outcome measures to assess a neglected area of need in the late effects clinic

British journal of haematology, 2014-02, Vol.164 (4), p.526-535

2014

Volltextzugriff (PDF)

A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma

Clinical lymphoma, myeloma and leukemia, 2024-05, Vol.24 (5), p.e191-e195.e6

2024

Volltextzugriff (PDF)

Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies

American journal of hematology, 2018-11, Vol.93 (11), p.1402-1410

2018

Volltextzugriff (PDF)

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone

Annals of hematology, 2017-02, Vol.96 (2), p.253-259

2017

Volltextzugriff (PDF)

Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

BMC gastroenterology, 2019-05, Vol.19 (1), p.82-82, Article 82

2019

Volltextzugriff (PDF)

Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse

Haematologica (Roma), 2013-04, Vol.98 (4), p.620-625

2013

Volltextzugriff (PDF)

Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial

Leukemia & lymphoma, 2016-06, Vol.57 (6), p.1291-1299

2016

Volltextzugriff (PDF)

Role of allogeneic hematopoietic stem-cell transplantation in chronic lymphocytic leukemia

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4864-4865

Gribben, John G

2008

Volltextzugriff (PDF)

Demonstration of durable graft versus lymphoma effects in Hodgkin's lymphoma

Journal of clinical oncology, 2011-03, Vol.29 (8), p.952-953

2011

Volltextzugriff (PDF)

Primary refractory T-cell prolymphocytic leukaemia treated with daily administration of Alemtuzumab plus high-dose methylprednisolone

European journal of haematology, 2014-04, Vol.92 (4), p.360-361

2014

Volltextzugriff (PDF)

Advances in chimeric antigen receptor immunotherapy for chronic lymphocytic leukemia

Discovery medicine, 2013-12, Vol.16 (90), p.295-302

2013

Volltextzugriff (PDF)

Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

Blood, 2014-12, Vol.124 (26), p.3841-3849

2014

Volltextzugriff (PDF)

Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia

Blood, 2008-03, Vol.111 (5), p.2790-2796

2008

Volltextzugriff (PDF)

Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?

Hematology/oncology clinics of North America, 2014-12, Vol.28 (6), p.1055-1071

2014

Volltextzugriff (PDF)

P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse

Blood, 2013-03, Vol.121 (12), p.2274-2284

2013

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Publikationsformmagazinearticle

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

Humans
(51)
Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Middle Aged
(34)
Female
(31)
Male
(31)
Adult
(30)
Hematology
(27)
Aged
(24)
Oncology
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(14)
Transplantation, Autologous
(14)
Prognosis
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Recurrence
(11)
Leukemia, Lymphocytic, Chronic, B-Cell - Mortality
(10)
Disease-Free Survival
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma at the Time of Second or Subsequent Remission: Long-Term Follow-Up

Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study

Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice

Fertility and sexual function in long‐term survivors of haematological malignancy: using patient‐reported outcome measures to assess a neglected area of need in the late effects clinic

A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma

Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone

Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse

Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial

Role of allogeneic hematopoietic stem-cell transplantation in chronic lymphocytic leukemia

Demonstration of durable graft versus lymphoma effects in Hodgkin's lymphoma

Primary refractory T-cell prolymphocytic leukaemia treated with daily administration of Alemtuzumab plus high-dose methylprednisolone

Advances in chimeric antigen receptor immunotherapy for chronic lymphocytic leukemia

Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997

Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia

Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?

P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse

Aktive Filter

Suchergebnisse filtern